| ²é¿´: 493 | »Ø¸´: 1 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
xiaowanzi9гæ (ÕýʽдÊÖ)
|
[ÇóÖú]
ÇóÖúÒ»¾ä»°·Òë
|
|
|
Reconcile study medication at appropriate points throughout the clinical study to ensure adequate oversight of control of study medication. Quantities refer to totals since initiation of the clinical study at this study site. ÔÚÕû¸öʵÑéÖÐÊʵ±µ÷½ÚʵÑéÒ©ÎïÒÔÈ·±£¶ÔÊÔÑéÒ©ÎïÓÐ×ã¹»µÄ¼à¶½¿ØÖÆ¡£ Reconcile study medication at appropriate points throughout the clinical study to ensure adequate oversight of control of study medication. Quantities refer to totals since initiation of the clinical study at this study site. |
» ²ÂÄãϲ»¶
ÉúÎïѧ303Çóµ÷¼Á£¬Ò»Ö¾Ô¸»ªÖÐũ΢ÉúÎÁù¼¶Òѹý£¬ÓпÆÑÐÓÐÎÄÕ£¬µ³Ô±
ÒѾÓÐ3È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
353Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
298Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸µç×ӿƼ¼´óѧ085600²ÄÁÏÓ뻯¹¤ 329·ÖÇóµ÷¼Á
ÒѾÓÐ9È˻ظ´
284Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
0817»¯Ñ§¹¤³ÌÓë¼¼ÊõÇóµ÷¼Á£¬Ò»Ö¾Ô¸Öк£Ñó319
ÒѾÓÐ11È˻ظ´
304Çóµ÷¼Á£¨085602£¬¹ýËļ¶£¬Ò»Ö¾Ô¸985£©
ÒѾÓÐ12È˻ظ´

ÀîÍØ°î
гæ (³õÈëÎÄ̳)
- ·ÒëEPI: 7
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 70.8
- ºì»¨: 2
- Ìû×Ó: 23
- ÔÚÏß: 12.7Сʱ
- ³æºÅ: 4264703
- ×¢²á: 2015-12-03
2Â¥2015-12-04 05:10:42














»Ø¸´´ËÂ¥